[HTML][HTML] Redefining chronic viral infection

HW Virgin, EJ Wherry, R Ahmed - Cell, 2009‏ - cell.com
Viruses that cause chronic infection constitute a stable but little-recognized part of our
metagenome: our virome. Ongoing immune responses hold these chronic viruses at bay …

Broadly neutralizing antiviral antibodies

D Corti, A Lanzavecchia - Annual review of immunology, 2013‏ - annualreviews.org
A fascinating aspect of viral evolution relates to the ability of viruses to escape the adaptive
immune response. The widely held view has been that the great variability of viral …

Targeting early infection to prevent HIV-1 mucosal transmission

AT Haase - Nature, 2010‏ - nature.com
Measures to prevent sexual mucosal transmission of human immunodeficiency virus (HIV)-1
are urgently needed to curb the growth of the acquired immunodeficiency syndrome (AIDS) …

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

R Diskin, JF Scheid, PM Marcovecchio, AP West Jr… - Science, 2011‏ - science.org
Antibodies against the CD4 binding site (CD4bs) on the HIV-1 spike protein gp120 can
show exceptional potency and breadth. We determined structures of NIH45-46, a more …

Systems vaccinology

B Pulendran, S Li, HI Nakaya - Immunity, 2010‏ - cell.com
Vaccination is one of the greatest triumphs of modern medicine, yet we remain largely
ignorant of the mechanisms by which successful vaccines stimulate protective immunity …

Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment

L Xu, Y Liu, Z Chen, W Li, Y Liu, L Wang, Y Liu… - Nano …, 2012‏ - ACS Publications
With the intense international response to the AIDS pandemic, HIV vaccines have been
extensively investigated but have failed due to issues of safety or efficacy in humans …

Challenges in the development of an HIV-1 vaccine

DH Barouch - Nature, 2008‏ - nature.com
The development of a safe and effective human immunodeficiency virus (HIV)-1 vaccine is a
critically important global health priority. Despite recent advances in our understanding of …

Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys

PR Johnson, BC Schnepp, J Zhang, MJ Connell… - Nature medicine, 2009‏ - nature.com
The key to an effective HIV vaccine is development of an immunogen that elicits persisting
antibodies with broad neutralizing activity against field strains of the virus. Unfortunately …

The antibody response against HIV-1

J Overbaugh, L Morris - Cold Spring …, 2012‏ - perspectivesinmedicine.cshlp.org
Neutralizing antibodies (NAbs) typically play a key role in controlling viral infections and
contribute to the protective effect of many successful vaccines. In the case of HIV-1 infection …

[HTML][HTML] A brief history of the global effort to develop a preventive HIV vaccine

J Esparza - Vaccine, 2013‏ - Elsevier
Soon after HIV was discovered as the cause of AIDS in 1983–1984, there was an
expectation that a preventive vaccine would be rapidly developed. In trying to achieve that …